← Back to catalogue

OxyPRAS Plus BBE/KVL Bi-Plate

FDA UDI

Class I (US FDA UDI)

by Oxyrase, Inc.

Identity

Trade Name
OxyPRAS Plus BBE/KVL Bi-Plate FDA UDI
Generic Name
Multiple formulation agar culture medium IVD FDA UDI
Device Name
Culture Media, Selective and Non-Differential FDA UDI
Model / Reference
B-BCD-KV FDA UDI
Description
Culture Media, Selective and Non-Differential FDA UDI

Identifiers

Catalog Number
B-BCD-KV FDA UDI
Primary DI / UDI-DI
00850056467025 FDA UDI
FDA Product Code
JSJ FDA UDI
GMDN Term
Multiple formulation agar culture medium IVD FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
866.2360 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

Yes

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Dimensions & Sizes

Size
Weight — 24 Gram FDA UDI

Category: Multiple formulation agar culture medium IVD

OxyPRAS Plus BBE/KVL Bi-Plate by Oxyrase, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Multiple formulation agar culture medium IVD.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Oxyrase, Inc.

Sources (1)

  • FDA UDI d2882a6a-6ebc-4d03-993d-1089052ab0e3 37 fields · synced May 30, 2026